BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9325306)

  • 1. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1).
    Rehemtulla A; Hamilton CA; Chinnaiyan AM; Dixit VM
    J Biol Chem; 1997 Oct; 272(41):25783-6. PubMed ID: 9325306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultraviolet-irradiation-induced apoptosis is mediated via ligand independent activation of tumor necrosis factor receptor 1.
    Sheikh MS; Antinore MJ; Huang Y; Fornace AJ
    Oncogene; 1998 Nov; 17(20):2555-63. PubMed ID: 9840918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
    Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
    Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet A radiation induces rapid apoptosis of human leukemia cells by Fas ligand-independent activation of the Fas death pathways.
    Zhuang S; Kochevar IE
    Photochem Photobiol; 2003 Jul; 78(1):61-7. PubMed ID: 12929750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.
    Wajant H; Johannes FJ; Haas E; Siemienski K; Schwenzer R; Schubert G; Weiss T; Grell M; Scheurich P
    Curr Biol; 1998 Jan; 8(2):113-6. PubMed ID: 9427646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA.
    Marsters SA; Pitti RM; Donahue CJ; Ruppert S; Bauer KD; Ashkenazi A
    Curr Biol; 1996 Jun; 6(6):750-2. PubMed ID: 8793301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain.
    Cohen O; Inbal B; Kissil JL; Raveh T; Berissi H; Spivak-Kroizaman T; Feinstein E; Kimchi A
    J Cell Biol; 1999 Jul; 146(1):141-8. PubMed ID: 10402466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95(Fas/APO-1) signals ceramide generation independent of the effector stage of apoptosis.
    Grullich C; Sullards MC; Fuks Z; Merrill AH; Kolesnick R
    J Biol Chem; 2000 Mar; 275(12):8650-6. PubMed ID: 10722705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
    J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard.
    Rosenthal DS; Velena A; Chou FP; Schlegel R; Ray R; Benton B; Anderson D; Smith WJ; Simbulan-Rosenthal CM
    J Biol Chem; 2003 Mar; 278(10):8531-40. PubMed ID: 12482751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
    Sprick MR; Weigand MA; Rieser E; Rauch CT; Juo P; Blenis J; Krammer PH; Walczak H
    Immunity; 2000 Jun; 12(6):599-609. PubMed ID: 10894160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis.
    Gómez-Angelats M; Cidlowski JA
    J Biol Chem; 2001 Nov; 276(48):44944-52. PubMed ID: 11581255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas- and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction.
    Bang S; Jeong EJ; Kim IK; Jung YK; Kim KS
    J Biol Chem; 2000 Nov; 275(46):36217-22. PubMed ID: 10952991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).
    Wajant H; Haas E; Schwenzer R; Muhlenbeck F; Kreuz S; Schubert G; Grell M; Smith C; Scheurich P
    J Biol Chem; 2000 Aug; 275(32):24357-66. PubMed ID: 10823821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression.
    Yeh JH; Hsu SC; Han SH; Lai MZ
    J Exp Med; 1998 Nov; 188(10):1795-802. PubMed ID: 9815257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
    Kischkel FC; Lawrence DA; Chuntharapai A; Schow P; Kim KJ; Ashkenazi A
    Immunity; 2000 Jun; 12(6):611-20. PubMed ID: 10894161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced by disruption of the actin cytoskeleton is mediated via activation of CD95 (Fas/APO-1).
    Kulms D; Düssmann H; Pöppelmann B; Ständer S; Schwarz A; Schwarz T
    Cell Death Differ; 2002 Jun; 9(6):598-608. PubMed ID: 12032668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.
    Chinnaiyan AM; O'Rourke K; Tewari M; Dixit VM
    Cell; 1995 May; 81(4):505-12. PubMed ID: 7538907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase.
    Scaffidi C; Volkland J; Blomberg I; Hoffmann I; Krammer PH; Peter ME
    J Immunol; 2000 Feb; 164(3):1236-42. PubMed ID: 10640736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.